Vanberra Signal
Empirasign logo

Empirasign

Curated by Signal

Alternative data provider delivering insights for fixed income markets.

Overview

Empirasign operates as an alternative data provider within the fintech ecosystem, focusing on delivering secondary market trading data for fixed income and structured products. The platform serves financial service firms by providing access to non-traditional data sets, including social media sentiment and supply chain information, which complement traditional financial analysis. Targeting sell-side and buy-side professionals, evaluated pricing companies, and auditing firms, Empirasign utilizes advanced analytics and machine learning to convert unstructured data into actionable insights. The platform offers customizable dashboards and integration capabilities to incorporate alternative data into existing investment workflows.

Key facts

Founded
2009

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Investment Technology companies
  • Alternative data provider offering evaluated bond pricing and indices.

    Investment TechnologyOslo, Norway
  • Alternative data provider offering insights for private investors and family offices.

    Investment TechnologyMakati, Philippines
  • Alternative data provider offering market intelligence on wealth management.

    Investment TechnologyLondon, United Kingdom
+ 474 more similar companies on Signal

About Empirasign

What does Empirasign do?

Empirasign operates as an alternative data provider within the fintech ecosystem, focusing on delivering secondary market trading data for fixed income and structured products.

Where is Empirasign headquartered?

Empirasign is headquartered in New York City, United States.

When was Empirasign founded?

Empirasign was founded in 2009.

Which sector is Empirasign in?

Empirasign operates in Investment Technology, part of Financial Technology.

Who are Empirasign's competitors?

Companies similar to Empirasign include Nordic Bond Pricing, Robur, and Highworth Research.